Foley Mark J 4
4 · Revance Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Foley Mark J
DirectorCEO
Transactions
- Award
Common Stock
2024-12-31$2.18/sh+1,000$2,185→ 996,935 total
Holdings
- 110,913(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These shares were acquired by Mr. Foley under the Issuer's 2014 Employee Stock Purchase Plan on December 31,2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.